As of July 7, 2017, pharmacies in West Virginia are required to report Gabapentin as a Drug of Concern to the state’s Controlled Substance Monitoring Program (CSMP).
The state also changed some ASAP field requirements on July 7, with more changes anticipated on August 15. These are noted in the state’s guide Changes to Data Submission.
Assistance and Support: For additional background, review the state’s guide Changes to Data Submission. For technical support, visit vendor RxDataTrack’s Controlled Substance Automated Prescription Program (CSAPP), email email@example.com or call 681.265.0340. If you have policy questions, visit the West Virginia Board of Pharmacy or call 304.558.0558.